Linda A. Miller

<i>In Vitro</i> Activity of Gepotidacin, a Novel Triazaacenaphthylene Bacterial Topoisomerase Inhibitor, against a Broad Spectrum of Bacterial Pathogens

Douglas J. Biedenbach, S. Bouchillon, Meredith Hackel et al. · Antimicrobial Agents and Chemotherapy · 2016 · 139 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Molecular Epidemiology of Methicillin-Resistant and Methicillin-Susceptible <i>Staphylococcus aureus</i> Isolates from Global Clinical Trials

Richard V. Goering, Ribhi M. Shawar, Nicole Scangarella et al. · Journal of Clinical Microbiology · 2008 · 115 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +15

Microbiological Analysis from a Phase 2 Randomized Study in Adults Evaluating Single Oral Doses of Gepotidacin in the Treatment of Uncomplicated Urogenital Gonorrhea Caused by Neisseria gonorrhoeae

Nicole E. Scangarella-Oman, Mohammad Hossain, Paula Dixon et al. · Antimicrobial Agents and Chemotherapy · 2018 · 101 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16

The Alexander Project: the benefits from a decade of surveillance

D. Felmingham, Anthony R. White, Michael R. Jacobs et al. · Journal of Antimicrobial Chemotherapy · 2005 · 92 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +17

<i>Acinetobacter baumannii</i> 2002–2008: Increase of Carbapenem-Associated Multiclass Resistance in the United States

Robertino M. Mera, Linda A. Miller, Heather Amrine‐Madsen et al. · Microbial Drug Resistance · 2010 · 81 citations

Life Sciences, Infectious Diseases, Microbiology +17